Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Chinese Patent Office
Fuji
Colorcon
Argus Health

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 7,524,872

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,524,872
Title:Method and composition for treating cancer using cellular organelle crystallizing agents
Abstract: This invention provides a method for treating cancer in mammals through cellular-organelle-crystallization-induced-death (herein defined as \"Cocid\"), a method for treating cancer using cellular organelle and/or cytoskeleton crystallizing agents (e.g. tetrazolium salts and their derivatives), pharmaceutical compositions containing a therapeutically effective amount of organelle and/or cytoskeleton crystallizing agents, and compositions containing organelle and/or cytoskeleton crystallizing agents in combination with a pharmaceutically acceptable carrier, diluent or excipient. The crystallizing agents with or without a pharmaceutically acceptable carrier, diluent or excipient, are used in combination with surgery and/or non-surgical anti-tumor treatments.
Inventor(s): Kong; Qingzhong (Jinan, Shandong Province 250100, CN)
Assignee:
Application Number:11/004,513
Patent Claims:see list of patent claims

Details for Patent 7,524,872

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up 2020-09-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,524,872

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 0182780 Jan 24, 2002
World Intellectual Property Organization (WIPO) 0182780 Nov 08, 2001
United States of America 2002086345 Jul 04, 2002
United States of America 2002143042 Oct 03, 2002
United States of America 2006286170 Dec 21, 2006
United States of America 6368818 Apr 09, 2002
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Covington
Julphar
Medtronic
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.